The expression of high-mobility group protein box 1 correlates with the progression of non-small cell lung cancer.
暂无分享,去创建一个
[1] Yan Ding,et al. Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma , 2008, The Journal of pathology.
[2] P. Rovere-Querini,et al. HMGB1: a two-headed signal regulating tumor progression and immunity. , 2008, Current opinion in immunology.
[3] T. Billiar,et al. HMGB1: Endogenous Danger Signaling , 2008, Molecular medicine.
[4] J. Bullerdiek,et al. Non-Hodgkin lymphoma expressing high levels of the danger-signalling protein HMGB1 , 2008, Leukemia & lymphoma.
[5] M. Lotze,et al. The grateful dead: damage‐associated molecular pattern molecules and reduction/oxidation regulate immunity , 2007, Immunological reviews.
[6] Laurence Zitvogel,et al. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy , 2007, Nature Medicine.
[7] Herbert J. Zeh,et al. Masquerader: High Mobility Group Box-1 and Cancer , 2007, Clinical Cancer Research.
[8] L. Ulloa,et al. High-mobility group box 1 (HMGB1) protein: friend and foe. , 2006, Cytokine & growth factor reviews.
[9] R. Donato,et al. The Amphoterin (HMGB1)/Receptor for Advanced Glycation End Products (RAGE) Pair Modulates Myoblast Proliferation, Apoptosis, Adhesiveness, Migration, and Invasiveness , 2006, Journal of Biological Chemistry.
[10] M. Presta,et al. Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine1 , 2006, The Journal of Immunology.
[11] S. Joos,et al. Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas , 2005, Gut.
[12] Kevin J. Tracey,et al. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.
[13] J. Enghild,et al. Purification and Characterization of Mouse Soluble Receptor for Advanced Glycation End Products (sRAGE)* , 2004, Journal of Biological Chemistry.
[14] R. Silber,et al. Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma. , 2004, Carcinogenesis.
[15] S. Müller,et al. Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function , 2004, Journal of internal medicine.
[16] K. Tracey,et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[17] Stefan Joos,et al. HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] Hoguen Kim,et al. Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation. , 2003, Cancer research.
[19] A. Bosserhoff,et al. Upregulation of HMG1 Leads to Melanoma Inhibitory Activity Expression in Malignant Melanoma Cells and Contributes to Their Malignancy Phenotype , 2003, Molecular and Cellular Biology.
[20] M. Bianchi,et al. HMGB proteins and gene expression. , 2003, Current opinion in genetics & development.
[21] K. Tracey,et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] L. Borrmann,et al. Variation of HMGB1 expression in breast cancer. , 2001, Anticancer research.
[23] T. Kislinger,et al. Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.
[24] K. Tracey,et al. HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.
[25] K. Sugimachi,et al. Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin. , 1996, Cancer research.
[26] H. Rauvala,et al. 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. , 1991, The Journal of biological chemistry.
[27] H. Fujii,et al. Expression of high mobility group box chromosomal protein-1 (HMGB-1) in gastric cancer. , 2007, Anticancer research.
[28] A. Bosserhoff,et al. Transcription factors involved in development and progression of malignant melanoma. , 2004, Histology and histopathology.